Regeneron acquires bankrupt DNA testing startup 23andMe and its data for $256 million
Regeneron Pharmaceuticals announced Monday that itβs buying βsubstantially allβ of 23andMeβs assets for $256 million. The deal comes just weeks after the once buzzy DNA testing startup, once valued near $6 billion, filed for Chapter 11 bankruptcy. According to Regeneron, [β¦]
The post Regeneron acquires bankrupt DNA testing startup 23andMe and its data for $256 million first appeared on Tech Startups.